Overview

Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the anti-atherosclerotic and anti-climacteric action of natural drug Karinat based on phytoestrogen-rich botanicals in perimenopausal women.
Phase:
Phase 3
Details
Lead Sponsor:
Institute for Atherosclerosis Research, Russia
Treatments:
alpha-Tocopherol
Ascorbic Acid
Beta Carotene
Estrogens